|
|
|
15.10.26 - 13:06
|
Quantum XChange Strengthens Advisory Board with Former BlackRock Chief Innovation Officer Kfir Godrich and Longtime Cisco Senior Executive Chris White (Business Wire)
|
|
|
Godrich joins as strategic advisor; White expands his role to help accelerate commercial strategy, GTM execution, sales and strategic partnerships.BETHESDA, Md.--(BUSINESS WIRE)--Quantum XChange®, a leader in quantum-safe network security, today announced that Kfir Godrich, former Managing Director and Chief Innovation Officer of BlackRock, has joined its advisory board. The company also announced an expanded role for advisor Chris White, a veteran technology executive whose leadership experience spans Cisco, Philips, Bloom Energy and Analog Devices. White will work with the leadership team to accelerate commercial strategy, go-to-market execution, sales and strategic partnerships as demand grows for post-quantum readiness.“Post-quantum readiness is becoming a board-level priority, and Kfir and Chris bring experience from both sides of that challenge,” said Eddy Zervigon, CEO of Quantum XChange. “Kfir has lived the problem our customers face. He was responsible for protecting and modernizing the in...
|
|
|
12.10.26 - 10:30
|
Philips Sector Perform (DPA-AFX)
|
|
|
NEW YORK (dpa-AFX Analyser) - Die kanadische Bank RBC hat die Einstufung für Philips auf "Sector Perform" mit einem Kursziel von 25 Euro belassen. Eine Warnung der US-Gesundheitsbehörde (FDA) für das Ultraschalldiagnostikgerät Lumify sei negativ zu werten, ......
|
|
|
|
|
|
|
|
|
|
|
09.10.26 - 14:24
|
Philips Neutral (DPA-AFX)
|
|
|
NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat Philips auf "Neutral" mit einem Kursziel von 23,50 Euro belassen. Für die Quartalszahlen des Medizintechnikkonzerns am 3. November lägen seine Schätzungen für den Umsatz knapp und für das bereinigte ......
|
|
|
|
|
06.10.26 - 11:21
|
Philips Market-Perform (DPA-AFX)
|
|
|
NEW YORK (dpa-AFX Analyser) - Das US-Analysehaus Bernstein Research hat die Einstufung für Philips auf "Market-Perform" mit einem Kursziel von 23,40 Euro belassen. Vor den Zahlen zum dritten Quartal aktualisierte Analystin Susannah Ludwig in einer am ......
|
|
|
05.10.26 - 15:24
|
Philips Sector Perform (DPA-AFX)
|
|
|
NEW YORK (dpa-AFX Analyser) - Die kanadische Bank RBC hat die Einstufung für Philips auf "Sector Perform" mit einem Kursziel von 25 Euro belassen. Analystin Natalia Webster aktualisierte in einem am Montag vorliegenden Kommentar ihre Prognosen für den ......
|
|
|
|
|
01.10.26 - 12:03
|
Philips Hold (DPA-AFX)
|
|
|
FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für Philips mit einem Kursziel von 24 Euro auf "Hold" belassen. "Werden die Niederländer ihre Jahresziele senken oder nicht?" ? Dies sei die zentrale Frage für den Quartalsbericht, ......
|
|
|
30.09.26 - 14:36
|
Philips Market-Perform (DPA-AFX)
|
|
|
NEW YORK (dpa-AFX Analyser) - Das US-Analysehaus Bernstein Research hat die Einstufung für Philips mit einem Kursziel von 23,40 Euro auf "Market-Perform" belassen. Die Niederländer erwarteten das Wachstum auf vergleichbarer Basis im dritten Quartal am ......
|
|
|
|
|
|
|
29.09.26 - 13:06
|
Elucid Appoints Mark Miller as Chief Revenue Officer to Lead Commercial Expansion Ahead of BioIntegrated FFR-CT Launch (Business Wire)
|
|
|
Veteran cardiovascular imaging and diagnostics sales leader to drive go-to-market strategy as Elucid prepares for FDA clearance of FFR-CTBOSTON--(BUSINESS WIRE)--#YesCCT--Elucid, a medical technology company using AI-powered, clinically validated software to advance precision diagnosis of cardiovascular disease, today announced that Mark Miller has joined the company as chief revenue officer (CRO). Miller will sit on Elucid's leadership team and report directly to CEO Kelly Huang, PhD. He joins the company ahead of the launch of its comprehensive cardiovascular platform, which is comprised of its FDA-cleared Plaque-IQ™ and its BioIntegrated FFR-CT software, pending FDA clearance.
Miller has more than 25 years of experience building and scaling sales organizations across cardiovascular imaging, cardiac diagnostics, and AI-enabled clinical decision support, grounded in a clinical foundation in cardiopulmonary science. He spent a decade between GE Healthcare and Philips, selling directly into cardiology p...
|
|
|
29.09.26 - 11:06
|
Philips Hold (DPA-AFX)
|
|
|
NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Philips mit einem Kursziel von 25 Euro auf "Hold" belassen. Analyst Julien Dormois rechnet für das dritte Quartal mit einem operativen Umsatzwachstum von 3 Prozent, wie er ......
|
|
|
22.09.26 - 08:12
|
The rise of Big Toothbrush: how did our mouths become such a lucrative market? (The Guardian)
|
|
|
People in the UK are more interested in oral health than ever - and you can now buy prebiotic toothpastes and brushes that cost up to £600. Yet we remain in the midst of a serious dental crisisA December 1969 report from the consumer magazine Which? explored a relatively new gadget that, it predicted, many people would be giving as Christmas presents: the electric toothbrush. For those who hadn't yet seen one, the magazine described it as “not that much different in principle from an ordinary brush – you have a stick with a brush on the end. The difference is that an electric one moves the brush head for you”. Progress indeed.Nearly six decades on, electric toothbrushes can do a lot more than merely jiggle, offering multiple speeds and movement sensors for real-time tracking of where you've brushed – some even promise gum-massage or tongue-cleaning modes. Prices range from about £25 for a basic Oral B model to £599.99 for a Philips Sonicare model that gives “smart coverage feedback”. The ...
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
